KIT and systemic mastocytosis: Thus, although KIT D816V has a central role in SM pathogenesis, it can be hypothesized that SETD2 and H3K36Me3 deficiency may cooperate with, and potentiate the effects of KIT constitutive activation to determine the phenotype of AdvSM.